Cardiovascular Business August 21, 2024
Venture capital (VC) investments in the medtech sector “held steady” in the second quarter of 2024, totaling $3.3 billion in deal value. This is down slightly from the $3.5 billion in deal value seen in the year’s first quarter, but still higher than investor activity in 2023.
That is all according to a new Pitchbook report focused on VC and private equity (PE) investments in the medtech industry.
“Despite quarterly variability, the current level of VC investment is a positive sign for the medtech VC landscape and lends credence to the view that the market has passed through the trough of investment activity,” according to the report.
Pitchbook noted that the quarter was led by $539.4 million worth of...
Today's Sponsors
Today's Sponsor